Evidence map›Paper›PMID 27768738›Full record

ArticlePloS one2016

MUC1-ARF-A Novel MUC1 Protein That Resides in the Nucleus and Is Expressed by Alternate Reading Frame Translation of MUC1 mRNA.

Michael Chalick, Oded Jacobi, Edward Pichinuk, Christian Garbar, Armand Bensussan, Alan Meeker, Ravit Ziv, Tania Zehavi, Nechama I Smorodinsky, John Hilkens and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. The alternative proteome in neurobiology.Frontiers in cellular neuroscience · 2022
    Review
  5. Article
  6. In vivo anti-MUC1Cancer immunology, immunotherapy : CII · 2020
    Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 5 countries.

Michael ChalickDepartment of Cell Research and Immunology, Tel Aviv University, Ramat Aviv, Israel.
Oded JacobiDepartment of Cell Research and Immunology, Tel Aviv University, Ramat Aviv, Israel.
Edward PichinukDepartment of Cell Research and Immunology, Tel Aviv University, Ramat Aviv, Israel.
Christian GarbarDepartment of Biopathology, Institut Jean-Godinot, Reims Cedex, France.
Armand BensussanINSERM U976, Hôpital Saint Louis, Paris, France.
Alan MeekerThe Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Ravit ZivDepartment of Cell Research and Immunology, Tel Aviv University, Ramat Aviv, Israel.
Tania ZehaviDepartment of Pathology, Meir Medical Center, Kfar Saba, Israel.
Nechama I SmorodinskyDepartment of Cell Research and Immunology, Tel Aviv University, Ramat Aviv, Israel.
John HilkensDivision of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Franz-Georg HanischInstitute of Biochemistry II, Medical Faculty, University of Cologne, Köln, Germany.
Daniel B RubinsteinBioModifying LLC, Silver Spring, Maryland, United States of America.
Daniel H WreschnerDepartment of Cell Research and Immunology, Tel Aviv University, Ramat Aviv, Israel.
Tel Aviv University · ILInserm · FRInstitut Jean Godinot · FRJohns Hopkins University · USMeir Medical Center · ILThe Netherlands Cancer Institute · NLUniversity of Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Translation of mRNA in alternate reading frames (ARF) is a naturally occurring process heretofore underappreciated as a generator of protein diversity. The MUC1 gene encodes MUC1-TM, a signal-transducing trans-membrane protein highly expressed in human malignancies. Here we show that an AUG codon downstream to the MUC1-TM initiation codon initiates an alternate reading frame thereby generating a novel protein, MUC1-ARF. MUC1-ARF, like its MUC1-TM 'parent' protein, contains a tandem repeat (VNTR) domain. However, the amino acid sequence of the MUC1-ARF tandem repeat as well as N- and C- sequences flanking it differ entirely from those of MUC1-TM. In vitro protein synthesis assays and extensive immunohistochemical as well as western blot analyses with MUC1-ARF specific monoclonal antibodies confirmed MUC1-ARF expression. Rather than being expressed at the cell membrane like MUC1-TM, immunostaining showed that MUC1-ARF protein localizes mainly in the nucleus: Immunohistochemical analyses of MUC1-expressing tissues demonstrated MUC1-ARF expression in the nuclei of secretory luminal epithelial cells. MUC1-ARF expression varies in different malignancies. While the malignant epithelial cells of pancreatic cancer show limited expression, in breast cancer tissue MUC1-ARF demonstrates strong nuclear expression. Proinflammatory cytokines upregulate expression of MUC1-ARF protein and co-immunoprecipitation analyses demonstrate association of MUC1-ARF with SH3 domain-containing proteins. Mass spectrometry performed on proteins coprecipitating with MUC1-ARF demonstrated Glucose-6-phosphate 1-dehydrogenase (G6PD) and Dynamin 2 (DNM2). These studies not only reveal that the MUC1 gene generates a previously unidentified MUC1-ARF protein, they also show that just like its 'parent' MUC1-TM protein, MUC1-ARF is apparently linked to signaling and malignancy, yet a definitive link to these processes and the roles it plays awaits a precise identification of its molecular functions. Comprising at least 524 amino acids, MUC1-ARF is, furthermore, the longest ARF protein heretofore described.

Indexed as

Protein BiosynthesisAnimalsBreast NeoplasmsCell Line, TumorCell NucleusCodonEnzyme-Linked Immunosorbent AssayFlow CytometryHumansMiceMucin-1Pancreatic NeoplasmsRNA, MessengerCodonMucin-1RNA, Messenger

Identifiers

PMID27768738
PMCPMC5074479
OpenAlexW2536537637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.